Systemic taurine treatment provides neuroprotection against retinal photoreceptor degeneration and visual function impairments

References

• Falsini B, Iarossi G, Chiaretti A, et al. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study. J Transl Med. 2016;14:8. doi:10.1186/s12967-016-0867-z26748988
   PubMed Web of Science ®Google Scholar
• Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795–1809. doi:10.1016/S0140-6736(06)69740-717113430
   PubMed Web of Science ®Google Scholar
• Guadagni V, Novelli E, Piano I, Gargini C, Strettoi E. Pharmacological approaches to retinitis pigmentosa: A laboratory perspective. Prog Retin Eye Res. 2015;48:62–81. doi:10.1016/j.preteyeres.2015.06.00526113212
   PubMed Web of Science ®Google Scholar
• Sorrentino FS, Gallenga CE, Bonifazzi C, Perri P. A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies. Eye. 2016;30:1542–1548. doi:10.1038/eye.2016.19727564722
   PubMed Web of Science ®Google Scholar
• Tsubura A, Yoshizawa K, Kuwata M, Uehara N. Animal models for retinitis pigmentosa induced by MNU; disease progression, mechanisms and therapeutic trials. Histol Histopathol. 2010;25:933–944. doi:10.14670/HH-25.93320503181
   PubMed Web of Science ®Google Scholar
• Reisenhofer MH, Balmer JM, Enzmann V. What can pharmacological models of retinal degeneration tell us? Curr Mol Med. 2017;17:100–107. doi:10.2174/156652401766617033116204828429669
   PubMed Web of Science ®Google Scholar
• Nomura-Komoike K, Saitoh F, Komoike Y, Fujieda H. DNA damage response in proliferating müller glia in the mammalian retina. Invest Ophthalmol Vis Sci. 2016;57:1169–1182. doi:10.1167/iovs.15-1810126975029
   PubMed Web of Science ®Google Scholar
• Emoto Y, Yoshizawa K, Kinoshita Y, Yuki M, Yuri T, Tsubura A. Susceptibility to N-methyl-N-nitrosourea-induced retinal degeneration in different rat strains. J Toxicol Pathol. 2016;29:67–71. doi:10.1293/tox.2015-006226989305
   PubMed Web of Science ®Google Scholar
• Comitato A, Sanges D, Rossi A, Humphries MM, Marigo V. Activation of Bax in three models of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014;13(55):3555–3562. doi:10.1167/iovs.14-13917
   Web of Science ®Google Scholar
• Sanvicens N, Cotter TG. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J Neurochem. 2006;98:1432–1434. doi:10.1111/j.1471-4159.2006.03977.x16923157
   PubMed Web of Science ®Google Scholar
• Tao Y, Geng L, Wang L, et al. Use of hydrogen as a novel therapeutic strategy against photoreceptor degeneration in retinitis pigmentosa patients. Med Sci Monit. 2016;22:776–779.26952558
   PubMed Web of Science ®Google Scholar
• Ripps H, Shen W. Review: taurine: a “very essential” amino acid. Mol Vis. 2012;18:2673–2686.23170060
   PubMed Web of Science ®Google Scholar
• Takatani T, Takahashi K, Uozumi Y, et al. Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. Biochem Biophys Res Commun. 2004;316:484–489. doi:10.1016/j.bbrc.2004.02.06615020243
   PubMed Web of Science ®Google Scholar
• Froger N, Moutsimilli L, Cadetti L, et al. Taurine: the comeback of a neutraceutical in the prevention of retinal degenerations. Prog Retin Eye Res. 2014;41:44–63. doi:10.1016/j.preteyeres.2014.03.00124721186
   PubMed Web of Science ®Google Scholar
• Froger N, Cadetti L, Lorach H, et al. Taurine provides neuroprotection against retinal ganglion cell degeneration. PLoS One. 2012;7:e42017. doi:10.1371/journal.pone.004201723115615
   PubMed Web of Science ®Google Scholar
• Lake N, Verdone-Smith C. Immunocytochemical localization of taurine in the mammalian retina. Curr Eye Res. 1989;8:163–173.2714101
   PubMed Web of Science ®Google Scholar
• Pasantes-Morales H, Domínguez L, Campomanes MA, Pacheco P. Retinal degeneration induced by taurine deficiency in light-deprived cats. Exp Eye Res. 1986;43:55–60.3732417
   PubMed Web of Science ®Google Scholar
• Hayes KC, Carey RE, Schmidt SY. Retinal degeneration associated with taurine deficiency in the cat. Science. 1975;188:949–951.1138364
   PubMed Web of Science ®Google Scholar
• Kretschmer F, Sajgo S, Kretschmer V. A system to measure the Optokinetic and Optomotor response in mice. J Neurosci Methods. 2015;256:91–105. doi:10.1016/j.jneumeth.2015.08.00726279344
   PubMed Web of Science ®Google Scholar
• Gaucher D, Arnault E, Husson Z, et al. Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino Acids. 2012;43:1979–1993. doi:10.1007/s00726-012-1273-322476345
   PubMed Web of Science ®Google Scholar
• Petit L, Punzo C. mTORC1 sustains vision in retinitis pigmentosa. Oncotarget. 2015;6:16786–16787. doi:10.18632/oncotarget.446626220206
   PubMedGoogle Scholar
• Cottet S, Schorderet DF. Mechanisms of apoptosis in retinitis pigmentosa. Curr Mol Med. 2009;9:375–383.19355918
   PubMed Web of Science ®Google Scholar
• Figueroa AL, Figueiredo H, Rebuffat SA, Vieira E, Gomis R. Taurine treatment modulates circadian rhythms in mice fed A high fat diet. Sci Rep. 2016;6:36801. doi:10.1038/srep3680127857215
   PubMed Web of Science ®Google Scholar
• Abd Elwahab AH, Ramadan BK, Schaalan MF, Tolba AM. A novel role of SIRT1/FGF-21 in taurine protection against cafeteria diet-induced steatohepatitis in rats. Cell Physiol Biochem. 2017;43:644–659. doi:10.1159/00048064928942443
   PubMedGoogle Scholar
• Rosa FT, Freitas EC, Deminice R, Jordão AA, Marchini JS. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014;53:823–830. doi:10.1007/s00394-013-0586-724065043
   PubMed Web of Science ®Google Scholar
• Kashani AH, Chen CL, Gahm JK, et al. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66–100. doi:10.1016/j.preteyeres.2017.07.00228760677
   PubMed Web of Science ®Google Scholar
• Rascher K, Servos G, Berthold G, et al. Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vision Res. 2004;44:2091–2100. doi:10.1016/j.visres.2004.03.02715149840
   PubMed Web of Science ®Google Scholar
• Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids. 2000;19(3–4):527–546.11140357
   PubMed Web of Science ®Google Scholar
• Hadj-Saïd W, Froger N, Ivkovic I, et al. Quantitative and topographical analysis of the losses of cone photoreceptors and retinal ganglion cells under taurine depletion. Invest Ophthalmol Vis Sci. 2016;57:4692–4703. doi:10.1167/iovs.16-1953527607415
   PubMed Web of Science ®Google Scholar
• Jammoul F, Dégardin J, Pain D, et al. Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treatedneonatal rats. Mol Cell Neurosci. 2010;43:414–421. doi:10.1016/j.mcn.2010.01.00820132888
   PubMed Web of Science ®Google Scholar
• García-Ayuso D, Di Pierdomenico J, Hadj-Said W, et al. Taurine depletion causes ipRGC loss and increases light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2018;59:1396–1409. doi:10.1167/iovs.17-2325829625463
   PubMed Web of Science ®Google Scholar
• Trouillet A, Dubus E, Dégardin J, et al. Cone degeneration is triggered by the absence of USH1 proteins but prevented by antioxidant treatments. Sci Rep. 2018;8(1):1968. doi:10.1038/s41598-018-20171-029386551
   PubMed Web of Science ®Google Scholar
• Oja SS, Saransaari P. Pharmacology of taurine. Proc West Pharmacol Soc. 2007;50:8–15.18605222
   PubMedGoogle Scholar
• Fletcher EL, Kalloniatis M. Neurochemical development of the degenerating rat retina. J Comp Neurol. 1997;388:1–22.9364235
   PubMed Web of Science ®Google Scholar
• Hadj-Saïd W, Fradot V, Ivkovic I, Sahel JA, Picaud S, Froger N. Taurine promotes retinal ganglion cell survival through GABAB receptor activation. Adv Exp Med Biol. 2017;975 Pt 2:687–701. doi:10.1007/978-94-024-1079-2_5428849492
   PubMed Web of Science ®Google Scholar
• Bulley S, Shen W. Reciprocal regulation between taurine and glutamate response via Ca2+-dependent pathways in retinal third-order neurons. J Biomed Sci. 2010;17 Suppl1:S5. doi:10.1186/1423-0127-17-S1-S520804625
   PubMed Web of Science ®Google Scholar
• El Idrissi A. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids. 2008;34:321–328. doi:10.1007/s00726-006-0396-916955229
   PubMed Web of Science ®Google Scholar
• Wu JY, Wu H, Jin Y, et al. Mechanism of neuroprotective function of taurine. Adv Exp Med Biol. 2009;643:169–179. doi:10.1007/978-0-387-75681-3_1719239147
   PubMed Web of Science ®Google Scholar
• Froger N, Jammoul F, Gaucher D, et al. Taurine is a crucial factor to preserve retinal ganglion cell survival. Adv Exp Med Biol. 2013;775:69–83. doi:10.1007/978-1-4614-6130-2_623392925
   PubMed Web of Science ®Google Scholar
• Huxtable RJ. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol. 1989;32:471–533.2664881
   PubMed Web of Science ®Google Scholar
• Schmidt SY, Aguirre GD. Reductions in taurine secondary to photoreceptor loss in Irish setters with rod-cone dysplasia. Invest Ophthalmol Vis Sci. 1985;26:679–683.3997418
   PubMed Web of Science ®Google Scholar
• Airaksinen EM, Sihvola P, Airaksinen MM, Sihvola M, Tuovinen E. Uptake of taurine by platelets in retinitis pigmentosa. Lancet. 1979;1:474–475.85058
   PubMed Web of Science ®Google Scholar
• Arshinoff SA, McCulloch JC, Macrae W, Stein AN, Marliss EB. Amino acids in retinitis pigmentosa. Br J Ophthalmol. 1981;65:626–630. doi:10.1136/bjo.65.9.6267295629
   PubMed Web of Science ®Google Scholar
• Narayan DS, Wood JP, Chidlow G, Casson RJ. A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmol. 2016;94:748–754. doi:10.1111/aos.1314127350263
   PubMed Web of Science ®Google Scholar
• Friedburg C, Serey L, Sharpe LT, Trauzettel-Klosinski S, Zrenner E. Evaluation of the Night Vision Spectacles on patients with impaired night vision. Graefes Arch Clin Exp Ophthalmol. 1999;237:125–3635.9987629
   PubMed Web of Science ®Google Scholar
• Tao Y, Chen T, Yang GQ, et al. Anthocyanin can arrest the cone photoreceptor degeneration and act as a novel treatment for retinitis pigmentosa. Int J Ophthalmol. 2016;9:153–158. doi:10.18240/ijo.2016.01.2526949626
   PubMed Web of Science ®Google Scholar
• Szél A, Röhlich P, Caffé AR, van Veen T. Distribution of cone photoreceptors in the mammalian retina. Microsc Res Tech. 1996;35(6):445–462. doi:10.1002/(SICI)1097-0029(19961215)35:6<445::AID-JEMT4>3.0.CO;2-H9016448
   PubMed Web of Science ®Google Scholar
• Viets K, Eldred K, Johnston RJ Jr. Mechanisms of photoreceptor patterning in vertebrates and invertebrates. Trends Genet. 2016;32(10):638–659. doi:10.1016/j.tig.2016.07.00427615122
   PubMed Web of Science ®Google Scholar
• Pasantes-Morales H, Quiroz H, Quesada O. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual fieldreduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis. 2002;17(3):183–197.12322788
   PubMed Web of Science ®Google Scholar
• Cangemi FE. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 2007;7:3. doi:10.1186/1471-2415-7-317324285
   PubMedGoogle Scholar
• Anderson CM, Howard A, Walters JR, Ganapathy V, Thwaites DT. Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6). J Physiol. 2009;587(Pt 4):731–744. doi:10.1113/jphysiol.2008.16422819074966
   PubMed Web of Science ®Google Scholar
• Sun M, Xu C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol N Eurobiol. 2008;28:593–611. doi:10.1007/s10571-007-9183-8
   PubMed Web of Science ®Google Scholar
• Lambert IH, Kristensen DM, Holm JB, Mortensen OH. Physiological role of taurine–from organism to organelle. Acta Physiol. 2015;213:191–212. doi:10.1111/apha.12365
   PubMed Web of Science ®Google Scholar